These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 18211115

  • 1. Pharmacokinetics and tissue penetration of moxifloxacin in intervention therapy for intra-abdominal abscess.
    Rink AD, Stass H, Delesen H, Kubitza D, Vestweber KH.
    Clin Drug Investig; 2008; 28(2):71-9. PubMed ID: 18211115
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics and peritoneal penetration of moxifloxacin in peritonitis.
    Stass H, Rink AD, Delesen H, Kubitza D, Vestweber KH.
    J Antimicrob Chemother; 2006 Sep; 58(3):693-6. PubMed ID: 16895940
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Pharmacokinetics of moxifloxacin in patients undergoing continuous ambulatory peritoneal dialysis.
    Skalioti C, Tsaganos T, Stamatiadis D, Giamarellos-Bourboulis EJ, Boletis J, Kanellakopoulou K.
    Perit Dial Int; 2009 Sep; 29(5):575-9. PubMed ID: 19776053
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Good penetration of moxifloxacin into human abscesses.
    Sauermann R, Karch R, Kjellsson MC, Feurstein T, Püspök A, Langenberger H, Böhmdorfer M, Jäger W, Zeitlinger M.
    Pharmacology; 2012 Sep; 90(3-4):146-50. PubMed ID: 22868236
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Penetration of moxifloxacin into liver tissue.
    Justinger C, Schilling MK, Kees MG, Kauffels A, Hirschmann K, Kopp B, Kees F, Kollmar O.
    Int J Antimicrob Agents; 2012 Jun; 39(6):505-9. PubMed ID: 22526014
    [Abstract] [Full Text] [Related]

  • 10. Pharmacokinetics and penetration of moxifloxacin into infected diabetic foot tissue in a large diabetic patient cohort.
    Majcher-Peszynska J, Sass M, Schipper S, Czaika V, Gussmann A, Lobmann R, Mundkowski RG, Luebbert C, Kujath P, Ruf BR, Koch H, Schareck W, Klar E, Drewelow B, Moxifloxacin-DFI Study Group.
    Eur J Clin Pharmacol; 2011 Feb; 67(2):135-42. PubMed ID: 20871984
    [Abstract] [Full Text] [Related]

  • 11. Penetration of moxifloxacin into the human pancreas following a single intravenous or oral dose.
    Wacke R, Förster S, Adam U, Mundkowski RG, Klar E, Hopt UT, Drewelow B.
    J Antimicrob Chemother; 2006 Nov; 58(5):994-9. PubMed ID: 16956903
    [Abstract] [Full Text] [Related]

  • 12. Ocular penetration and pharmacokinetics of topical gatifloxacin 0.3% and moxifloxacin 0.5% ophthalmic solutions after keratoplasty.
    Holland EJ, Lane SS, Kim T, Raizman M, Dunn S.
    Cornea; 2008 Apr; 27(3):314-9. PubMed ID: 18362660
    [Abstract] [Full Text] [Related]

  • 13. Population pharmacokinetics of moxifloxacin in plasma and bronchial secretions in patients with severe bronchopneumonia.
    Simon N, Sampol E, Albanese J, Martin C, Arvis P, Urien S, Lacarelle B, Bruguerolle B.
    Clin Pharmacol Ther; 2003 Oct; 74(4):353-63. PubMed ID: 14534522
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.